Clinical Trials associated with Dr. Pfleger Arzneimittel GmbH
DRKS00032952
/ RecruitingNot Applicable
Open-label, controlled, randomized, multicenter study to demonstrate the effect of the INKA digital therapy companion on symptoms of overactive bladder (with or without urinary incontinence). - C-23-413
Bioequivalence study of two oral fixed-dose combination tablets of 250 mg acetylsalicylic acid, 250 mg paracetamol and 65 mg caffeine in healthy volunteers after controlled fasting - P360
Investigation of a medical device (ipalat® Hydro Med Lutschpastille) on saliva production andon changes in salivary surface tension in healthy subjects with dry mouth - P363
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.